Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 23, 2021
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
[ Tue, Mar 23rd 2021
] - WOPRAI
Mon, March 22, 2021
[ Mon, Mar 22nd 2021
] - WOPRAI
[ Mon, Mar 22nd 2021
] - WOPRAI
[ Mon, Mar 22nd 2021
] - WOPRAI
[ Mon, Mar 22nd 2021
] - WOPRAI
Tessa Romero Initiated (YMAB) at Buy and Held Target at $52 on, Mar 22nd, 2021
Tessa Romero of JP Morgan, Initiated "Y-mAbs Therapeutics, Inc." (YMAB) at Buy and Held Target at $52 on, Mar 22nd, 2021.
Tessa has made no other calls on YMAB in the last 4 months.
There are 2 other peers that have a rating on YMAB. Out of the 2 peers that are also analyzing YMAB, 1 agrees with Tessa's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoff Meacham of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $56 on, Friday, January 15th, 2021
This is the rating of the analyst that currently disagrees with Tessa
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $70 on, Monday, March 1st, 2021
